View Detailed Profile
Accelerating Medicines Partnership® Program – Type 2 Diabetes Project

Accelerating Medicines Partnership® Program – Type 2 Diabetes Project

The

Accelerating Medicines Partnership® (AMP®)

Accelerating Medicines Partnership® (AMP®)

The FNIH manages the

The Accelerating Medicines Partnership® (AMP®) program in schizophrenia (AMP SCZ): Overview & Vision

The Accelerating Medicines Partnership® (AMP®) program in schizophrenia (AMP SCZ): Overview & Vision

The

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: May 21, 2020 webinar

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: May 21, 2020 webinar

Title:

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: July 16th, 2020 webinar

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: July 16th, 2020 webinar

Accelerating Medicines Partnership Type

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: Introductory Workshop

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: Introductory Workshop

Accelerating Medicines Partnership Type

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: Spring webinar

Accelerating Medicines Partnership Type 2 Diabetes Knowledge Portal: Spring webinar

Accelerating Medicines Partnership Type

Launching the Accelerating Medicines Partnership (AMP)

Launching the Accelerating Medicines Partnership (AMP)

Announcement of the

Accelerating Medicines Partnership - Alzheimer's Disease

Accelerating Medicines Partnership - Alzheimer's Disease

The

OTA-24-008: Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership Webinar

OTA-24-008: Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership Webinar

The NIH Common Fund Venture Space recently published a new Research Opportunity Announcement (ROA), OTA-24-008, ...

AMP® Autoimmune and Immune-Mediated Diseases

AMP® Autoimmune and Immune-Mediated Diseases

Our mission is to advance

AMP® Symposium Day 1: Parkinson's Disease

AMP® Symposium Day 1: Parkinson's Disease

The

AMP® Symposium Day 1: Panel Discussion - 10 Years of AMP Impacts

AMP® Symposium Day 1: Panel Discussion - 10 Years of AMP Impacts

The